New Healthcare research report from Business Monitor International is now available from Fast Market Research
Boston, MA -- (SBWIRE) -- 12/10/2013 -- Despite the delicate macroeconomic situation in Central America, the pharmaceutical market -consisting of the seven markets of Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and Belize - is set to grow. Local authorities' emphasis on healthcare investment should translate into higher consumption of medicines. However, the region's low per capita pharmaceutical spending and generic drugs' high market share has limited multinationals' growth potential in the region.
Headline Expenditure Projections
- Pharmaceuticals: US$3.5bn in 2012 to US$3.7bn in 2013; +4.9%. Our forecast has been revised slightly upwards since Q413 due to more optimistic macroeconomic data.
- Healthcare: US$15.4bn in 2012 to US$16.6bn in 2013; +8.1 %. Our forecast has been revised upwards since Q413 due to more optimistic macroeconomic data.
View Full Report Details and Table of Contents
Risk/Reward Ratings: In BMI's Q114 Pharmaceutical Risk/Reward Ratings (RRRs), the Americas scores 67 out of 100, below the Western Europe region (67), Central and Eastern Europe (52), the Asia Pacific (52) and above the Middle East and Africa (42) region. Of the seven Central American countries surveyed in BMI's RRRs Panama ranks first, followed by Costa Rica (40.8), Guatemala (37.6), El Salvador (37), Belize (36.9), Honduras (32.6) and Nicaragua (32.3).
Key Trends And Developments
- In August 2013, Costa Rica's public health system inaugurated a new centre worth US$18mn. The new facility is situated in one of the major hospitals in San Jose and was inaugurated by Costa Rican President Laura Chinchilla.
- In August 2013, the Costa Rican social security administration (Caja Costarricense de Seguro Social, CCSS) saved US$1.5mn in annual pharmaceutical procurement through the Council of Ministers of Health from Central America and Dominican Republic (COMISCA).
- In July 2013, Honduras planned to allocate a US$50mn loan from the Inter-American Development Bank (IDB) to improve its health services, especially in rural areas. The IDB financing consists of a 30-year term US$35mn loan from ordinary capital, with a grace period of five-and-a-half years and an interest rate based on LIBOR. The remaining US$15mn is from the Fund for Special Operations, with a 40-year term and grace period and 0.25% interest rate. The program aims to strengthen the capacity of the Ministry of Health (SESAL) and improve its efficiency and quality of services. The government plans to double the number of beneficiaries by 2015.
- In July 2013, Kielsa Pharmaceutical, a Honduran pharmacy chain, opened its first pharmacy in Managua, Nicaragua. It offers products at prices up to 50% lower than those from local pharmacies and plans to open ten large pharmacies in Managua in its first year and generate US$80mn in sales annually from Nicaragua.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Healthcare research reports at Fast Market Research
You may also be interested in these related reports:
- Middle East and Africa and South and Central America Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems
- Turkey Pharmaceuticals & Healthcare Report Q1 2014
- Slovenia Pharmaceuticals & Healthcare Report Q1 2014
- Latvia Pharmaceuticals & Healthcare Report Q1 2014
- Croatia Pharmaceuticals & Healthcare Report Q1 2014
- Netherlands Pharmaceuticals & Healthcare Report Q1 2014
- Australia Pharmaceuticals & Healthcare Report Q1 2014
- Nigeria Pharmaceuticals & Healthcare Report Q1 2014
- Oman Pharmaceuticals & Healthcare Report Q1 2014
- Mexico Pharmaceuticals & Healthcare Report Q1 2014